Related people
Irina is a member of the Practice Area Patents Technology and Life Sciences and the Life Science & Healthcare Industry Group. She advises national and international pharmaceutical and medical device companies on regulatory aspects and industry-specific agreements.
Since 2023 | Senior Associate, Taylor Wessing |
2020 | Associate, Taylor Wessing |
2020 | Lawyer at a public body in the health care sector in Munich |
2017 – 2019 | Legal clerkship, Higher Regional Court of Munich |
2015 – 2018 | Research and teaching Assistant, department of civil law and medical law, Ludwigs Maximilians University, Munich |
2020 | Admitted as a lawyer, Munich |
2019 | Second state examination, Munich |
2014 – 2018 | PhD programme at Ludwig Maximilians University in Munich |
2013 | First state examination, Goettingen |
§ 2 ProdHaftG, comment in: Gsell/Krüger/Lorenz/Reymann: Beck-OGK regarding civil law |
English |
Latest news & insights
R&D Collaborations | Coffee Break Life Sciences Start-ups #4
Germany as a location for pharmaceutical businesses - quo vadis, 2024?
Strategy paper by the German Federal Government on improving the regulatory framework for the pharmaceutical industry in Germany
by Dr. Manja Epping and Irina Rebin
JUVE Awards 2023: Taylor Wessing named "Law Firm of the Year for IP”
by multiple authors
The Long and Winding Road: (Some) EU and FDA Issues to Consider with Clinical Trials and Clinical Trial Agreements
by Dr. Manja Epping and Irina Rebin